David Tyronne Howton, Jr

2016

In 2016, David Tyronne Howton, Jr earned a total compensation of $2.3M as Senior Vice President, General Counsel and Corporate Secretary at Sarepta Therapeutics, a 30% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$195,445
Option Awards$715,566
Salary$407,176
Stock Awards$996,553
Other$12,718
Total$2,327,458

Howton received $996.6K in stock awards, accounting for 43% of the total pay in 2016.

Howton also received $195.4K in non-equity incentive plan, $715.6K in option awards, $407.2K in salary and $12.7K in other compensation.

Rankings

In 2016, David Tyronne Howton, Jr's compensation ranked 4,219th out of 14,075 executives tracked by ExecPay. In other words, Howton earned more than 70.0% of executives.

ClassificationRankingPercentile
All
4,219
out of 14,075
70th
Division
Manufacturing
1,475
out of 5,488
73rd
Major group
Chemicals And Allied Products
444
out of 1,900
77th
Industry group
Drugs
322
out of 1,543
79th
Industry
Pharmaceutical Preparations
253
out of 1,173
78th
Source: SEC filing on April 27, 2017.

Howton's colleagues

We found four more compensation records of executives who worked with David Tyronne Howton, Jr at Sarepta Therapeutics in 2016.

2016

Edward Kaye

Sarepta Therapeutics

Chief Executive Officer

2016

Sandesh Mahatme

Sarepta Therapeutics

Chief Financial Officer

2016

Shamim Ruff

Sarepta Therapeutics

Senior Vice President, Regulatory Affairs and Quality

2016

Alexander Cumbo

Sarepta Therapeutics

Senior Vice President, Global Commercial Operations

News

You may also like